Open Access

ADAM17 promotes lymph node metastasis in gastric cancer via activation of the Notch and Wnt signaling pathways

  • Authors:
    • Wei Li
    • Daguang Wang
    • Xuan Sun
    • Yang Zhang
    • Lei Wang
    • Jian Suo
  • View Affiliations

  • Published online on: December 17, 2018     https://doi.org/10.3892/ijmm.2018.4028
  • Pages: 914-926
  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Disintegrin and metalloproteinase domain-containing proteins (ADAMs) have been implicated in cell adhesion, signaling and migration. The aim of the present study was to identify key members of the ADAM protein family associated with the metastasis of gastric cancer and to evaluate their clinical significance. A total of 193 patients with gastric cancer and positive lymph node metastasis were enrolled. Key members of the ADAM family associated with lymph node metastasis were identified. The correlations between survival times and the clinicopathological features of patients were investigated. Furthermore, ADAM17 expression in gastric cancer cells with different metastatic potentials was determined. ADAM17 was overexpressed in BGC‑823 cells and suppressed in SGC‑7901 cells to further investigate its effects on cell viability and migration. The key pathways associated with ADAM17 were identified by gene set enrichment analysis (GSEA). It was found that ADAM9 and ADAM17 were significantly upregulated in gastric cancer and positive metastatic lymph node tissues. Further, there was a strong correlation between the survival times of patients and ADAM17 expression. ADAM17 was upregulated in gastric cancer cells with high metastatic potential. The viability of BGC‑823 cells significantly increased following ADAM17 overexpression, whereas the viability and migration of SGC‑7901 cells decreased following ADAM17 suppression. GSEA and western blot analysis revealed a positive correlation between the Notch and Wnt signaling pathways with ADAM17 expression. In conclusion, the increased expression of ADAM17 promoted the progression of gastric cancer, potentially via Notch and/or Wnt signaling pathway activation, and ADAM17 may serve as a useful prognostic marker.
View Figures
View References

Related Articles

Journal Cover

February-2019
Volume 43 Issue 2

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li W, Wang D, Sun X, Zhang Y, Wang L and Suo J: ADAM17 promotes lymph node metastasis in gastric cancer via activation of the Notch and Wnt signaling pathways. Int J Mol Med 43: 914-926, 2019
APA
Li, W., Wang, D., Sun, X., Zhang, Y., Wang, L., & Suo, J. (2019). ADAM17 promotes lymph node metastasis in gastric cancer via activation of the Notch and Wnt signaling pathways. International Journal of Molecular Medicine, 43, 914-926. https://doi.org/10.3892/ijmm.2018.4028
MLA
Li, W., Wang, D., Sun, X., Zhang, Y., Wang, L., Suo, J."ADAM17 promotes lymph node metastasis in gastric cancer via activation of the Notch and Wnt signaling pathways". International Journal of Molecular Medicine 43.2 (2019): 914-926.
Chicago
Li, W., Wang, D., Sun, X., Zhang, Y., Wang, L., Suo, J."ADAM17 promotes lymph node metastasis in gastric cancer via activation of the Notch and Wnt signaling pathways". International Journal of Molecular Medicine 43, no. 2 (2019): 914-926. https://doi.org/10.3892/ijmm.2018.4028